Speciality: Hepatologist
Description:
Welcome to our podcast. Today, we’re exploring recent advances in hepatology—the study of the liver. Over the past few years, breakthroughs in diagnostics and treatment have significantly improved outcomes for liver disease patients. Non-invasive imaging techniques now allow earlier and more accurate diagnosis, reducing the need for painful biopsies. In addition, new antiviral therapies have revolutionised the treatment of hepatitis B and C, leading to higher cure rates. We’re also seeing progress in regenerative medicine, where stem cell therapies show promise for liver regeneration. These innovations mean better quality of life and hope for millions. Stay tuned as we continue to track developments in this exciting field.
See More Webinars @ Hidoc Webinars
1.
CAR T-Cell Therapy in Functional High-Risk Multiple Myeloma
2.
According to a study, taking part in a clinical trial for cancer may not actually increase survival.
3.
Orca-T Approved to Prevent GVHD After Stem Cell Transplant for Blood Cancers
4.
Adjuvant Combination for Kidney Cancer Gets FDA's Blessing
5.
TKI Discontinuation Feasible After ALL Treatment
1.
Abemaciclib in Combination with Therapies for Patients with Metastatic Breast Cancer
2.
Importance of Early Detection in Hematology
3.
Reproductive Hormones and Immune Cell Metabolism: Mechanisms, Clinical Implications, and Emerging Evidence
4.
Clonal Hematopoiesis as a Mechanism of Age-Related Disease
5.
Unleashing the Inner Predator: Reprogramming Macrophages to Conquer Cancer Immunotherapy
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
2.
Efficient Management of First line ALK-rearranged NSCLC - Part II
3.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
4.
Expert Perspectives on Hematology
5.
Screening for Red Cell Membrane Disorders Through Ektacytometry-Based Deformability Profiling
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation